Xsphera Biosciences Inc — Form D
Xsphera Biosciences Inc of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2023-05-04. The offering totals $19.9M, of which $12.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-05-04
- Form: D
- Accession: 0001934197-23-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $19.9M
- Amount sold: $12.6M
- Remaining: $7.3M
- Investors: 40
- Date of first sale: 2023-04-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-480877
Issuer
- Name: Xsphera Biosciences Inc
- CIK: 0001934197
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 6 TIDE STREET, BOSTON, MA, 02110
- Phone: 6178323030
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Stephen Remondi | Director | Boston, MA |
| Robert Walsh | Director | Bedford, TX |
| Stephen Remondi | Executive Officer | Boston, MA |
Other filings by this issuer (1)
More